Natriumchlorid Serag-Wiessner (Sodium Chloride)

Natriumchlorid Serag‑Wiessner is used in clinical situations that require restoration of intravascular volume and electrolyte balance.

• Fluid and electrolyte replacement: reconstitutes sodium and chloride levels and supports circulatory volume.
• Hypovolemia: corrects low blood volume caused by bleeding or severe dehydration.
• Dehydration: provides rapid rehydration in acute settings.
• Surgical patients: maintains electrolyte homeostasis during peri‑operative care.

• Sodium chloride administered intravenously dissociates into sodium (Na⁺) and chloride (Cl⁻) ions, which are readily absorbed into the extracellular compartment. The ions increase plasma osmolarity, drawing water into the vascular space and expanding intravascular volume. This restores electrolyte concentrations, supports nerve and muscle function, and helps maintain blood pressure and tissue perfusion.

Adverse reactions may occur with intravenous sodium chloride administration.

Common Side Effects

• Injection site pain or irritation.
• Mild hypernatremia (elevated serum sodium).
• Mild hypokalemia (reduced serum potassium).
• Fluid overload in susceptible patients.
• Local phlebitis.
• Transient hypertension.

Serious or Rare Side Effects

• Severe hypernatremia leading to neurological symptoms.
• Anaphylactic or severe allergic reaction.
• Pulmonary edema due to excessive fluid administration.
• Cardiac arrhythmias from electrolyte imbalance.
• Metabolic acidosis in extreme cases.
• Renal impairment exacerbated by volume overload.

When using Natriumchlorid Serag‑Wiessner, clinicians should observe several safety measures.

• Assess baseline electrolyte levels: verify sodium, chloride, and potassium before infusion.
• Monitor fluid balance: track input and output to avoid overload.
• Use caution in renal impairment: adjust volume and rate as needed.
• Avoid rapid infusion in cardiac patients: administer slowly to prevent strain.
• Store at ambient temperature: keep in original container, protect from moisture and direct light.

Intravenous sodium chloride can interact with other therapies that affect fluid or electrolyte status.

Major Interactions (Avoid)

• Concurrent hypertonic saline solutions: risk of severe hypernatremia.
• Combination with high‑dose diuretics: may cause profound electrolyte shifts.

Moderate Interactions (Monitor Closely)

• Potassium supplements: monitor for hypokalemia.
• ACE inhibitors or ARBs: watch for altered renal perfusion.
• NSAIDs: may affect renal function and fluid handling.